Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 417

1.

A global view of hepatocellular carcinoma: trends, risk, prevention and management.

Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR.

Nat Rev Gastroenterol Hepatol. 2019 Aug 22. doi: 10.1038/s41575-019-0186-y. [Epub ahead of print] Review.

PMID:
31439937
2.

An Empirical Validation of the Within-subject Biospecimens Pooling Approach to Minimize Exposure Misclassification in Biomarker-based Studies.

Vernet C, Philippat C, Agier L, Calafat AM, Ye X, Lyon-Caen S, Hainaut P, Siroux V, Schisterman EF, Slama R.

Epidemiology. 2019 Sep;30(5):756-767. doi: 10.1097/EDE.0000000000001056.

PMID:
31373935
3.

LKB1 specifies neural crest cell fates through pyruvate-alanine cycling.

Radu AG, Torch S, Fauvelle F, Pernet-Gallay K, Lucas A, Blervaque R, Delmas V, Schlattner U, Lafanechère L, Hainaut P, Tricaud N, Pingault V, Bondurand N, Bardeesy N, Larue L, Thibert C, Billaud M.

Sci Adv. 2019 Jul 17;5(7):eaau5106. doi: 10.1126/sciadv.aau5106. eCollection 2019 Jul.

4.

[Dyspnea in a 64 year-old woman].

Pothen L, Yildiz H, Aydin S, Camboni A, Lambert M, Hainaut P, Ebbo M.

Rev Med Interne. 2019 Jul 13. pii: S0248-8663(19)30555-7. doi: 10.1016/j.revmed.2019.06.009. [Epub ahead of print] French. No abstract available.

PMID:
31311673
5.

Nephrotic syndrome without kidney injury revealing intravascular large B cell lymphoma.

Pothen L, Aydin S, Camboni A, Hainaut P.

BMJ Case Rep. 2019 Jun 12;12(6). pii: e229359. doi: 10.1136/bcr-2019-229359.

PMID:
31196971
6.

Pulmonary Edema: Consider an Unusual Suspect.

Jopart C, Hainaut P, Ghaye B.

J Belg Soc Radiol. 2019 May 15;103(1):33. doi: 10.5334/jbsr.1819. No abstract available.

7.

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome caused by first-line antituberculosis drugs: Two case reports and a review of the literature.

Coster A, Aerts O, Herman A, Marot L, Horst N, Kenyon C, Vlieghe E, Hainaut P, Baeck M.

Contact Dermatitis. 2019 Apr 25. doi: 10.1111/cod.13296. [Epub ahead of print]

PMID:
31021423
8.

Response to: Concern regarding classification of germlineTP53 variants as likely pathogenic.

de Andrade KC, Frone MN, Wegman-Ostrosky T, Khincha PP, Kim J, Amadou A, Santiago KM, Fortes FP, Lemonnier N, Mirabello L, Stewart DR, Hainaut P, Kowalski LP, Savage SA, Achatz MI.

Hum Mutat. 2019 Jun;40(6):832-833. doi: 10.1002/humu.23749. Epub 2019 Apr 18. No abstract available.

PMID:
30997946
9.

Cost-effectiveness of early cancer surveillance for patients with Li-Fraumeni syndrome.

Tak CR, Biltaji E, Kohlmann W, Maese L, Hainaut P, Villani A, Malkin D, Sherwin CMT, Brixner DI, Schiffman JD.

Pediatr Blood Cancer. 2019 May;66(5):e27629. doi: 10.1002/pbc.27629. Epub 2019 Feb 4.

PMID:
30719841
10.

p53, stem cell biology and childhood blastomas.

Oh L, Hafsi H, Hainaut P, Ariffin H.

Curr Opin Oncol. 2019 Mar;31(2):84-91. doi: 10.1097/CCO.0000000000000504.

PMID:
30585860
11.

Variable population prevalence estimates of germline TP53 variants: A gnomAD-based analysis.

de Andrade KC, Frone MN, Wegman-Ostrosky T, Khincha PP, Kim J, Amadou A, Santiago KM, Fortes FP, Lemonnier N, Mirabello L, Stewart DR, Hainaut P, Kowalski LP, Savage SA, Achatz MI.

Hum Mutat. 2019 Jan;40(1):97-105. doi: 10.1002/humu.23673. Epub 2018 Nov 19.

PMID:
30352134
12.

Systems medicine disease maps: community-driven comprehensive representation of disease mechanisms.

Mazein A, Ostaszewski M, Kuperstein I, Watterson S, Le Novère N, Lefaudeux D, De Meulder B, Pellet J, Balaur I, Saqi M, Nogueira MM, He F, Parton A, Lemonnier N, Gawron P, Gebel S, Hainaut P, Ollert M, Dogrusoz U, Barillot E, Zinovyev A, Schneider R, Balling R, Auffray C.

NPJ Syst Biol Appl. 2018 Jun 2;4:21. doi: 10.1038/s41540-018-0059-y. eCollection 2018.

13.

Correction to: Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study.

Cohen AT, Ay C, Hainaut P, Décousus H, Hoffmann U, Gaine S, Coppens M, da Silva PM, Jimenez D, Amann-Vesti B, Brüggenjürgen B, Levy P, Bastida JL, Vicaut E, Laeis P, Fronk EM, Zierhut W, Malzer T, Bramlage P, Agnelli G; ETNA-VTE-Europe investigators.

Thromb J. 2018 May 31;16:18. doi: 10.1186/s12959-018-0173-5. eCollection 2018.

14.

Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study.

Cohen AT, Ay C, Hainaut P, Décousus H, Hoffmann U, Gaine S, Coppens M, da Silva PM, Castro DJ, Amann-Vesti B, Brüggenjürgen B, Levy P, Bastida JL, Vicaut E, Laeis P, Fronk EM, Zierhut W, Malzer T, Bramlage P, Agnelli G; ETNA-VTE-Europe investigators.

Thromb J. 2018 May 1;16:9. doi: 10.1186/s12959-018-0163-7. eCollection 2018. Erratum in: Thromb J. 2018 May 31;16:18.

15.

Pulmonary Tumor Microembolism: When the Pathologist Looks Further Than the Radiologist.

De Greef J, Hainaut P.

Am J Med. 2018 Aug;131(8):e323. doi: 10.1016/j.amjmed.2018.03.007. Epub 2018 Mar 27. No abstract available.

PMID:
29596785
16.

Combination of AKT inhibitor ARQ 092 and sorafenib potentiates inhibition of tumor progression in cirrhotic rat model of hepatocellular carcinoma.

Jilkova ZM, Kuyucu AZ, Kurma K, Ahmad Pour ST, Roth GS, Abbadessa G, Yu Y, Schwartz B, Sturm N, Marche PN, Hainaut P, Decaens T.

Oncotarget. 2018 Jan 23;9(13):11145-11158. doi: 10.18632/oncotarget.24298. eCollection 2018 Feb 16.

17.

ALK fusion variants detection by targeted RNA-next generation sequencing and clinical responses to crizotinib in ALK-positive non-small cell lung cancer.

McLeer-Florin A, Duruisseaux M, Pinsolle J, Dubourd S, Mondet J, Phillips Houlbracq M, Magnat N, Fauré J, Chatagnon A, de Fraipont F, Giaj Levra M, Toffart AC, Ferretti G, Hainaut P, Brambilla E, Moro-Sibilot D, Lantuejoul S.

Lung Cancer. 2018 Feb;116:15-24. doi: 10.1016/j.lungcan.2017.12.004. Epub 2017 Dec 8.

PMID:
29413046
18.

Revisiting tumor patterns and penetrance in germline TP53 mutation carriers: temporal phases of Li-Fraumeni syndrome.

Amadou A, Waddington Achatz MI, Hainaut P.

Curr Opin Oncol. 2018 Jan;30(1):23-29. doi: 10.1097/CCO.0000000000000423. Review. Erratum in: Curr Opin Oncol. 2019 Jan;31(1):52.

PMID:
29076966
19.

Training the Next Generation of Biobankers: A Two-Year Master's Course in the Management of Biobanks.

Gormally E, Hardy I, Caboux E, di Donato JH, Hainaut P, Hofman P.

Biopreserv Biobank. 2017 Oct;15(5):438-450. doi: 10.1089/bio.2017.0002. Epub 2017 Sep 18.

PMID:
28922617
20.

Higher-than-expected population prevalence of potentially pathogenic germline TP53 variants in individuals unselected for cancer history.

de Andrade KC, Mirabello L, Stewart DR, Karlins E, Koster R, Wang M, Gapstur SM, Gaudet MM, Freedman ND, Landi MT, Lemonnier N, Hainaut P, Savage SA, Achatz MI.

Hum Mutat. 2017 Dec;38(12):1723-1730. doi: 10.1002/humu.23320. Epub 2017 Sep 21.

PMID:
28861920

Supplemental Content

Loading ...
Support Center